HEART
PALPITATE
ASYSTOLE
DEFIB
SHOCK
100

Standard number of leads used in continuous cardiac monitoring.

5 leads

100

: First-line drug given for symptomatic bradycardia.

Atropine

100

Primary purpose of a central venous catheter.

Monitor central venous pressure or administer vasopressors

100

First-line vasopressor for septic shock.

Norepinephrine

100

First step of the nursing process.

Assessment

200

Common ECG change seen during myocardial ischemia.

ST depression

200

First action for pulseless ventricular tachycardia.

Defibrillation

200

Device used to deliver IV medications in precise amounts.

Infusion pump

200

Anticoagulant that requires aPTT monitoring.

Heparin

200

Tool used to assess level of consciousness in ICU patients.

Glasgow Coma Scale

300

Life-threatening arrhythmia risk associated with a prolonged QT interval.

Torsades de Pointes

300

Acronym used in ACLS during cardiac arrest.

CAB (Circulation, Airway, Breathing)

300

Preferred site for arterial line insertion.

Radial artery

300

Major side effect associated with long-term use of amiodarone.

Pulmonary toxicity

300

Nursing intervention to reduce ICU delirium.

Promote sleep and orientation

400

Electrolyte imbalance commonly associated with peaked T-waves.

Hyperkalemia

400

Time frame for administering fibrinolytics in acute MI.

Within 30 minutes of hospital arrival

400

Nursing intervention that helps prevent ventilator-associated pneumonia

Elevate head of bed to 30–45 degrees

400

Main cardiac effect of dobutamine.

Increases myocardial contractility

400

Best patient position to enhance oxygenation in ARDS.

Prone position

500

Leads used to detect anterior wall myocardial infarction.

V1 to V4

500

A reversible cause of pulseless electrical activity due to fluid in the pericardial sac.

Cardiac tamponade

500

Typical range for ventilator high-pressure alarm settings.

20–30 cm H₂O

500

Drug used to reverse opioid overdose.

Naloxone

500

Ethical principle that supports a patient’s right to withdraw life support.

Autonomy

M
e
n
u